Acute disseminated encephalomyelitis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
{{Acute disseminated encephalomyelitis}}
{{Acute disseminated encephalomyelitis}}
{{CMG}}; {{AE}}
{{CMG}}; {{AE}}{{SHM}}


'''''Synonyms and Keywords:''''' post infectious [[encephalomyelitis]]; [[Autoimmune]] [[demyelinating disease]] of [[central nervous system]]
'''''Synonyms and Keywords:''''' post infectious [[encephalomyelitis]]; [[Autoimmune]] [[demyelinating disease]] of [[central nervous system]]
Line 17: Line 15:
==[[Acute disseminated encephalomyelitis differential diagnosis|Differentiating Acute disseminated encephalomyelitis from other Diseases]]==
==[[Acute disseminated encephalomyelitis differential diagnosis|Differentiating Acute disseminated encephalomyelitis from other Diseases]]==


== [[Acute disseminated encephalomyelitis epidemiology and demographics|Epidemiology and Demographics]] ==
==[[Acute disseminated encephalomyelitis epidemiology and demographics|Epidemiology and Demographics]]==
[[Category: (name of the system)]]
[[Category: (name of the system)]]


== [[Acute disseminated encephalomyelitis risk factors|Risk Factors]] ==
==[[Acute disseminated encephalomyelitis risk factors|Risk Factors]]==


==[[Acute disseminated encephalomyelitis screening|Screening]]==
==[[Acute disseminated encephalomyelitis screening|Screening]]==
Line 32: Line 30:
[[Acute disseminated encephalomyelitis medical therapy|Medical Therapy]] | [[Acute disseminated encephalomyelitis surgery|Surgery]] | [[Acute disseminated encephalomyelitis primary prevention|Primary Prevention]] | [[Acute disseminated encephalomyelitis secondary prevention|Secondary Prevention]] | [[Acute disseminated encephalomyelitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acute disseminated encephalomyelitis future or investigational therapies|Future or Investigational Therapies]]
[[Acute disseminated encephalomyelitis medical therapy|Medical Therapy]] | [[Acute disseminated encephalomyelitis surgery|Surgery]] | [[Acute disseminated encephalomyelitis primary prevention|Primary Prevention]] | [[Acute disseminated encephalomyelitis secondary prevention|Secondary Prevention]] | [[Acute disseminated encephalomyelitis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Acute disseminated encephalomyelitis future or investigational therapies|Future or Investigational Therapies]]


== Case Studies ==
==Case Studies==
[[Acute disseminated encephalomyelitis case study one|Case #1]]
[[Acute disseminated encephalomyelitis case study one|Case #1]]



Revision as of 02:16, 28 July 2021

Acute disseminated encephalomyelitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute disseminated encephalomyelitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute disseminated encephalomyelitis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute disseminated encephalomyelitis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute disseminated encephalomyelitis

CDC on Acute disseminated encephalomyelitis

Acute disseminated encephalomyelitis in the news

Blogs on Acute disseminated encephalomyelitis

Directions to Hospitals Treating Acute disseminated encephalomyelitis

Risk calculators and risk factors for Acute disseminated encephalomyelitis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shameera Shaik Masthan MBBS, DLO, DNB[2]

Synonyms and Keywords: post infectious encephalomyelitis; Autoimmune demyelinating disease of central nervous system


Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute disseminated encephalomyelitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Acknowledgements

The content on this page was first contributed by: ELLISON L. SMITH, M.D.

Related Chapters

External links

  • Acute Disseminated Encephalomyelitis (ADEM)Information page-> including pathogenesis/aetiology/treatment/prognosis at adem.org
  • Acute Disseminated Encephalomyelitis (ADEM) at myelitis.org
  • Murthy J (2002). "Acute disseminated encephalomyelitis". Neurology India. 50 (3): 238–43. PMID 12391446.


References

Template:Diseases of the nervous system

de:Akute disseminierte Enzephalomyelitis nl:Acute gedissemineerde encefalomyelitis fi:Akuutti disseminoitunut enkefalomyeliitti

Template:WH Template:WS